Cargando…
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
Mutation and overexpression of p53 occurs in 20-40% of breast cancers and has been shown to be an independent prognostic indicator. Recently we have demonstrated prostate-specific antigen (PSA) expression in breast tumours to be suggestive of favourable prognosis, but quantitative relationships betw...
Autores principales: | Levesque, M. A., Clark, G. M., Yu, H., Diamandis, E. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033897/ https://www.ncbi.nlm.nih.gov/pubmed/7545416 |
Ejemplares similares
-
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination
por: Yu, H, et al.
Publicado: (1999) -
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
por: Hoffman, B R, et al.
Publicado: (2002) -
Prostate-specific antigen in serum of women with breast cancer.
por: Giai, M., et al.
Publicado: (1995) -
Cocaine Detection by a Laser-Induced Immunofluorometric Biosensor
por: Paul, Martin, et al.
Publicado: (2021) -
Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.
por: Yu, H., et al.
Publicado: (1996)